Cleared Traditional

K073289 - MICROSHEATH XL CATHETERS

K073289 is an FDA 510(k) clearance for MICROSHEATH XL CATHETERS, manufactured by Flowcardia, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 51-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2008
Decision
51d
Days
Class 2
Risk

K073289 is an FDA 510(k) clearance for the MICROSHEATH XL CATHETERS. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Flowcardia, Inc. (Sunnyvale, US). The FDA issued a Cleared decision on January 11, 2008 after a review of 51 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Flowcardia, Inc. devices

FDA 510(k) Submission Details - K073289

510(k) Number K073289 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 21, 2007
Decision Date January 11, 2008
Days to Decision 51 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
74d faster than avg
Panel avg: 125d · This submission: 51d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 669
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K073289.
SCOUTPRO CS LEAD INTRODUCER SYSTEM
K080988 · Biotronik, Inc. · May 2008
SCOUTPRO 8F, 7F AND SLITTER TOOL ADVANCED
K072329 · Biotronik, Inc. · Mar 2008
ACUITY UNIVERSAL CUTTER
K080154 · Cardiac Pacemakers, Inc. · Mar 2008
ADVANCE 18LP PTA DILATATION CATHETER
K073378 · Cook, Inc. · Dec 2007
SPECTRANETICS QUICK-CROSS SUPPORT2 CATHETERS, MODELS 518-065 AND 518-066
K072750 · Spectranetics Corp. · Dec 2007
TWIN-PASS OTW CATHETER, MODEL 5201
K072618 · Vascular Solutions, Inc. · Nov 2007